However, relying on such panels can miss other mutant alleles, as demonstrated by a 2019 study that fully sequenced GBA1 in an Ashkenazi Jewish Parkinson disease patient cohort (Ruskey et al., 2019). The gene discussed is GBA1; the disease is Parkinson disease.